QL
NTLA icon

Quarry LP’s Intellia Therapeutics NTLA Stock Holding History

Quarry LP’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-237
Closed -$2.22K – 2398
2025
Q2 		$2.22K Buy
+237
New +$1.95K ﹤0.01% 1576
2024
Q2 		– Sell
-1,800
Closed -$49.5K – 2014
2024
Q1 		$49.5K Buy
+1,800
New +$50K 0.01% 466
2023
Q4 		– Sell
-1,500
Closed -$47.4K – 1547
2023
Q3 		$47.4K Buy
+1,500
New +$58.2K 0.01% 341

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quarry LP's NTLA Position: Q3 2025 in Review

Quarry LP sold out of Intellia Therapeutics (NTLA) in Q3 2025, closing a stake of 237 shares — an estimated $2.22K sold.

Quarry LP first reported a position in NTLA in Q3 2023 and held it in 3 quarters. The position peaked at $49.5K in Q1 2024. 282 funds tracked by Wall St. Rank hold NTLA as of Q3 2025.

  • Quarry LP reported no remaining Intellia Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Quarry LP sold 237 Intellia Therapeutics shares in Q3 2025, an estimated $2.22K.
  • Quarry LP first reported a position in Intellia Therapeutics in Q3 2023 and held it in 3 quarters.
  • Quarry LP's Intellia Therapeutics position peaked at $49.5K in Q1 2024.
  • 282 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2025.

Based on Quarry LP's 13F filing for Q3 2025, filed 14 Nov 2025.